Mount Sinai Speaker Bios

Kenneth L. Davis, MD
CEO and President, Mount Sinai Health System

Kenneth L. Davis, MD, is the CEO and President of the Mount Sinai Health System in New York City, one of the nation’s largest and most highly honored integrated health systems. The Health System encompasses the Icahn School of Medicine at Mount Sinai and seven hospital campuses and has a large ambulatory footprint. As a neurobiologist, Dr. Davis’s pioneering research in Alzheimer’s disease led the U.S. Food and Drug Administration to approve four of the first five drugs for the treatment of Alzheimer’s disease. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences, and, over the course of his career, he has received tens of millions of dollars of National Institutes of Health grants to study major brain diseases. The author or co-author of more than 575 scientific articles, Dr. Davis has been recognized as one of the most highly cited researchers in the field of brain diseases. He has won awards for his research from several organizations, most notably, the Alzheimer’s Association, the Society of Biological Psychiatry, and the American Psychiatric Association. He was also awarded the George H. W. Bush Lifetime of Leadership Award from Yale University, where he was an undergraduate. In 2014, he was named a trustee of the Aspen Institute.

Eric Nestler, MD, PhD
Professor and Chair, Neuroscience, and Director of The Friedman Brain Institute at Icahn School of Medicine at Mount Sinai

Eric Nestler, MD, PhD, is Professor and Chair of Neuroscience and Director of The Friedman Brain Institute at Icahn School of Medicine at Mount Sinai. His work uses animal models to better understand the molecular mechanisms behind addiction and depression, aiming to develop improved treatments for these disorders. He was elected to the Institute of Medicine of the National Academies and is a former President of the American College of Neuropsychopharmacology and former Council Member of the Society for Neuroscience. He was named among the 400 most highly influential biomedical scientists in the world by the European Journal of Clinical Investigators (2013), and he co-headlined a panel on “Addiction” at the World Science Festival in New York City. As one of the most highly-cited researchers in his field, Dr. Nestler published research in the journal Nature (2014) that challenged current opinions about depression and treatment drugs. He has received tens of millions of dollars of National Institutes of Health grants to study major brain diseases, and he is the recipient of many awards, including the Rhoda and Bernard Sarnat International Prize in Mental Health (Institute of Medicine) and the Patricia-Goldman-Rakic Prize (NARSAD) and received an honorary doctorate from the University of Uppsala.

Brian S. Koll, MD, FACP, FIDSA
Professor of Medicine, Icahn School of Medicine at Mount Sinai, and Executive Medical Director for Infection Prevention and Control for the Mount Sinai Health System

Brian S. Koll, MD, FACP, FIDSA, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, is the Executive Medical Director for Infection Prevention and Control for the Mount Sinai Health System and a nationally renowned, award-winning infection prevention expert. In his role at Mount Sinai, he leads the preparedness efforts to ensure the safety of staff, patients, and their families. In 2014, under Dr. Koll’s leadership, The Mount Sinai Hospital served as an Ebola Treatment Center for the State of New York. More than a dozen persons of interest for Ebola were evaluated at the Mount Sinai Health System. He has received numerous infection prevention grants from the U.S. Centers for Disease Control and Prevention, the Public Health Research Institute, the Agency for Healthcare Research and Quality, the National Institutes of Health, and the New York State Department of Health. Dr. Koll is a 2010 National Association for Professionals in Infection Control Hero of Infection Prevention, and additionally he has received three Pinnacle Awards for Quality and Patient Safety from the Healthcare Association of New York State and two awards from the U.S. Department of Health and Human Services for outstanding achievement and leadership in eliminating healthcare-associated infections.